As of 2025-09-18, the EV/EBITDA ratio of Insmed Inc (INSM) is -32.89. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INSM's latest enterprise value is 29,881.92 mil USD. INSM's TTM EBITDA according to its financial statements is -908.56 mil USD. Dividing these 2 quantities gives us the above INSM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.1x - 15.9x | 15.9x |
| Forward P/E multiples | 13.7x - 16.9x | 15.5x |
| Fair Price | (57.03) - (64.94) | (64.08) |
| Upside | -139.4% - -144.9% | -144.3% |
| Date | EV/EBITDA |
| 2025-09-17 | -32.89 |
| 2025-09-16 | -32.88 |
| 2025-09-15 | -32.51 |
| 2025-09-12 | -33.16 |
| 2025-09-11 | -33.12 |
| 2025-09-10 | -33.16 |
| 2025-09-09 | -33.45 |
| 2025-09-08 | -33.33 |
| 2025-09-05 | -32.96 |
| 2025-09-04 | -32.37 |
| 2025-09-03 | -32.59 |
| 2025-09-02 | -33.01 |
| 2025-08-29 | -30.87 |
| 2025-08-28 | -30.61 |
| 2025-08-27 | -30.50 |
| 2025-08-26 | -29.96 |
| 2025-08-25 | -29.06 |
| 2025-08-22 | -29.89 |
| 2025-08-21 | -30.06 |
| 2025-08-20 | -29.32 |
| 2025-08-19 | -28.80 |
| 2025-08-18 | -28.82 |
| 2025-08-15 | -28.94 |
| 2025-08-14 | -28.93 |
| 2025-08-13 | -27.79 |
| 2025-08-12 | -27.59 |
| 2025-08-11 | -25.47 |
| 2025-08-08 | -24.69 |
| 2025-08-07 | -24.64 |
| 2025-08-06 | -25.09 |
| 2025-08-05 | -25.17 |
| 2025-08-04 | -25.09 |
| 2025-08-01 | -24.49 |
| 2025-07-31 | -24.17 |
| 2025-07-30 | -23.68 |
| 2025-07-29 | -23.63 |
| 2025-07-28 | -22.88 |
| 2025-07-25 | -23.39 |
| 2025-07-24 | -23.29 |
| 2025-07-23 | -23.27 |
| 2025-07-22 | -23.15 |
| 2025-07-21 | -23.12 |
| 2025-07-18 | -23.07 |
| 2025-07-17 | -23.44 |
| 2025-07-16 | -23.54 |
| 2025-07-15 | -23.14 |
| 2025-07-14 | -22.91 |
| 2025-07-11 | -22.05 |
| 2025-07-10 | -21.69 |
| 2025-07-09 | -21.65 |